What’s at stake: The cost of getting it wrong
Investigations are exhausting because the stakes are so high and the timelines so long. A single sterility test failure can put millions of dollars at risk through delayed release or lost batches. Mid-range and senior experts are pulled into investigations for months, often while still carrying their day jobs. Entire teams operate under sustained pressure, and exhaustion becomes a constant undercurrent.
That’s because sterility tests are apart of the final check before drugs are released to patients. These are products that go straight into the bloodstream. They must be absolutely sterile. The risk of infection from even a single microorganism that shouldn’t be there is real.
What makes sterility test investigations even harder is that in many cases, the true cause is never found; yet teams are still required to demonstrate rigorous diligence, exploring every plausible scenario and presenting a defensible case to regulators. This is because microorganisms are microscopic, and therefore impossible to see with the naked eye. Depending on the organism, growth in sterility test media may be rapid or very slow, with failures detected anywhere from early in the test window to much later.
And sterility tests capture only a single moment in time. Since both laboratory and manufacturing protocols require constant cleaning, potential evidence is routinely removed. It’s like cleaning up the scene of the crime every single day.